Intracranial ependymomas of childhood: long-term outcome and prognostic factors
- PMID: 8559293
- DOI: 10.1227/00006123-199510000-00008
Intracranial ependymomas of childhood: long-term outcome and prognostic factors
Abstract
A detailed outcome analysis was performed on 40 children with intracranial ependymomas treated at our institution between 1975 and 1993 to identify those factors that were predictive of overall and progression-free survival. Three patients (7.5%) who were treated in the first 5 years of the study died within 3 months of surgery and were excluded from further outcome assessments. Eight (22%) of the 37 patients who survived the perioperative period had evidence of leptomeningeal dissemination at presentation, on the basis of either imaging (three children) and/or cytological (six children) results. The 5- and 10-year progression-free survival rates among these 37 patients were 45.1 and 36.1%, respectively; overall survival rates were 57.1 and 45.0%, respectively. The site of progression was local in 17 of 19 patients with progressive disease. Three factors were found to have a significant association (P < or = 0.05) with the outcome on both univariate and multivariate analyses: 1) the extent of the resection, 2) the age of the patient at diagnosis, and 3) the duration of the symptoms before diagnosis. The 5-year progression-free and overall survivals were 8.9 and 22%, respectively, among patients who had evidence of residual disease on postoperative imaging studies, compared with 68 and 80% rates among patients with no apparent residual disease (P = 0.0001 and P < 0.0001, respectively). Patients younger than 3 years fared significantly worse than older children (5-year progression-free and overall survival rates of 12 and 22%, respectively, in the younger children versus 60 and 75% in older children (P = 0.003 and P = 0.01, respectively). In addition, patients with a duration of symptoms before diagnosis of < 1 month had a worse outcome than those with a more protracted course (5-year progression-free and overall survival rates of 33 and 33%, respectively, versus rates of 53 and 64%, respectively (P = 0.02 for both). Neither the finding of evidence for dissemination at presentation nor the detection of anaplastic histological features (e.g., dense cellularity or high numbers of mitoses) were associated with a significantly worse outcome in this series. The combination of variables that had the strongest association with both favorable and unfavorable outcomes was the combination of the age of the patient and the resection extent. Only 2 of 17 patients older than 3 years with gross total resections have died, whereas 13 of 20 children who were either younger than 3 years or had radiologically incomplete resections have died (P < 0.0001).(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Prognostic factors in intracranial ependymomas in children.J Neurosurg. 2000 Oct;93(4):605-13. doi: 10.3171/jns.2000.93.4.0605. J Neurosurg. 2000. PMID: 11014538
-
Intracranial ependymomas: analysis of prognostic factors in a population-based series.Pediatr Neurosurg. 1996;24(3):119-25. doi: 10.1159/000121027. Pediatr Neurosurg. 1996. PMID: 8870014
-
Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group.J Neurosurg. 1998 Apr;88(4):695-703. doi: 10.3171/jns.1998.88.4.0695. J Neurosurg. 1998. PMID: 9525716 Clinical Trial.
-
Intracranial ependymomas of childhood: current management strategies.Pediatr Neurosurg. 2000 Sep;33(3):138-50. doi: 10.1159/000028995. Pediatr Neurosurg. 2000. PMID: 11096361 Review.
-
Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors.J Neurosurg. 2016 Aug;125(2):410-8. doi: 10.3171/2015.7.JNS151187. Epub 2016 Jan 8. J Neurosurg. 2016. PMID: 26745489 Review.
Cited by
-
Malignant Transformation of Grade II Ependymoma in a 2-Year-Old Child: Case Report.J Neurol Surg Rep. 2015 Jul;76(1):e151-5. doi: 10.1055/s-0035-1549311. Epub 2015 Apr 27. J Neurol Surg Rep. 2015. PMID: 26251794 Free PMC article.
-
Stereotactic radiosurgery for patients with recurrent intracranial ependymomas.J Neurooncol. 2012 Jul;108(3):507-12. doi: 10.1007/s11060-012-0851-2. Epub 2012 Mar 23. J Neurooncol. 2012. PMID: 22437346
-
Supratentorial and Infratentorial Ependymoma.Adv Tech Stand Neurosurg. 2024;53:93-118. doi: 10.1007/978-3-031-67077-0_7. Adv Tech Stand Neurosurg. 2024. PMID: 39287805 Review.
-
Pediatric surgical neuro-oncology: current best care practices and strategies.J Neurooncol. 2004 Aug-Sep;69(1-3):139-50. doi: 10.1023/b:neon.0000041877.14749.b6. J Neurooncol. 2004. PMID: 15527086 Review.
-
The management of completely resected childhood intracranial ependymoma: the argument for observation only.Childs Nerv Syst. 2009 Mar;25(3):281-4. doi: 10.1007/s00381-008-0799-x. Epub 2009 Jan 20. Childs Nerv Syst. 2009. PMID: 19153750 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical